Department of Pharmaceutical Chemistry, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand.
Drug and Herbal Product Research and Development Center, College of Pharmacy, Rangsit University, Pathum Thani, 12000, Thailand.
BMC Complement Med Ther. 2023 Feb 10;23(1):43. doi: 10.1186/s12906-023-03862-8.
The phytochemical study of medicinal plants is rapidly gaining popularity with many pharmacologic effects. This study aims to determine the antioxidant capacity as well as anticancer and antimigration activities of Clear belongs Plus extract (CBL-P) which consisted of five medicinal plants namely, Alpinia galanga, Piper nigrum, Citrus aurantifolia, Tiliacora triandra, and Cannabis sativa on human colon cancer cells SW620 and HCT116 cell lines, and human non-small cell lung cancer cells A549 and NCI-H460 cell lines.
In this study the dried-plant powder was extracted using 90% ethanol. Additionally, CBL-P was studied antioxidative activity via DPPH and ABTS assays and anti-inflammatory activities using nitric oxide assay using Griess reaction. Antiproliferation and antimigration of CBL-P were investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and scratch assay.
The results showed that CBL-P had potent antiproliferative activity with IC values in a concentration- and time-dependent manners for all four cell lines. CBL-P also possessed potent antimigration activity against all studied cancer cells. CBL-P demonstrated antimigration activity on four different types of cancer cells (A549, NCI-H460, HCT116, and SW620) after 48 h of incubation, with the greatest effect seen at the highest concentration tested (15 μg/mL) in A549 cells (10.23% of wound closure) and NCI-H460 cells (9.16% of wound closure). CBL-P was also effective in reducing migration in HCT116 and SW620 cells, with a range of closure area from 10-50%. In addition, CBL-P had antioxidant activity with IC values of 8.549 ± 0.241 mg/mL and 2.673 ± 0.437 mg/mL for DPPH and ABTS assays, respectively. CBL-P also showed anti-inflammatory activity with the best inhibitory activity on NO production at a concentration of 40 μg/mL.
In conclusion, the mixture extract possessed antioxidant and anti-inflammatory activity. Furthermore, the mixture plant extract significantly exhibited antiproliferative and antimigration activities on SW620, HCT116, A549, and NCI-H460 cells (P ≤ 0.05). Taken together, our results suggest that medicinal plants may have synergistic effects that could potentially enhance the effectiveness of cancer treatment when used as adjuvants. These findings provide a solid scientific foundation for future efforts to explore the mechanism of action.
药用植物的植物化学研究正迅速受到关注,具有许多药理作用。本研究旨在确定由五种药用植物组成的 Clear belongs Plus 提取物(CBL-P)的抗氧化能力以及对人结肠癌细胞 SW620 和 HCT116 细胞系和人非小细胞肺癌细胞 A549 和 NCI-H460 细胞系的抗癌和抗迁移活性。
在这项研究中,使用 90%乙醇提取干燥植物粉末。此外,通过 DPPH 和 ABTS 测定法研究 CBL-P 的抗氧化活性,通过格里斯反应研究一氧化氮测定法的抗炎活性。使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H-四唑溴盐 (MTT) 和划痕试验研究 CBL-P 的增殖和迁移抑制作用。
结果表明,CBL-P 对所有四种细胞系均具有浓度和时间依赖性的强效增殖抑制活性。CBL-P 对所有研究的癌细胞也具有强大的抗迁移活性。CBL-P 在孵育 48 小时后对四种不同类型的癌细胞(A549、NCI-H460、HCT116 和 SW620)表现出抗迁移活性,在最高测试浓度(15 μg/mL)时对 A549 细胞(闭合伤口的 10.23%)和 NCI-H460 细胞(闭合伤口的 9.16%)的效果最大。CBL-P 还能有效减少 HCT116 和 SW620 细胞的迁移,闭合面积范围为 10-50%。此外,CBL-P 具有抗氧化活性,DPPH 和 ABTS 测定的 IC 值分别为 8.549±0.241mg/mL 和 2.673±0.437mg/mL。CBL-P 还表现出抗炎活性,在 40μg/mL 浓度下对 NO 产生的抑制活性最佳。
总之,该混合物提取物具有抗氧化和抗炎活性。此外,该混合物植物提取物在 SW620、HCT116、A549 和 NCI-H460 细胞上显著表现出抗增殖和抗迁移活性(P≤0.05)。综上所述,我们的研究结果表明,药用植物可能具有协同作用,作为佐剂使用时可能会增强癌症治疗的效果。这些发现为进一步探索作用机制提供了坚实的科学基础。